The S&P BSE Healthcare index is marginally in the red at -0.10% in early trade, while broader markets (Sensex +0.52%, Nifty 50 +0.39%) are positive. Most losses in the pharma sector are small, with mid-cap names leading the declines.
Notable movers (gainers)
Sudeep Pharma is the top gainer on both exchanges, up 0.93% on BSE and 0.99% on NSE, trading at ₹634.55 and ₹634.90 respectively.
Strides Pharma Science follows, up 0.87% on BSE (₹1,011.00) and 0.94% on NSE (₹1,011.05).
Divis Laboratories is the largest cap among the gainers, up 0.67% on BSE at ₹6,218.00 and 0.74% on NSE at ₹6,223.00.
Panacea Biotech is up 0.55% on BSE (₹348.60) and 0.26% on NSE (₹347.85).
Alembic Pharma has gained 0.51% on BSE (₹738.70) and 0.39% on NSE (₹737.65).
Notable movers (losers)
Ajanta Pharma is the biggest loser in early trade, down 1.53% on BSE at ₹2,844.10 and -1.03% on NSE at ₹2,853.50.
Glenmark Pharma is down 1.23% on BSE (₹2,232.45) and -1.12% on NSE (₹2,233.00).
Lupin has declined 1.08% on BSE (₹2,313.85) and 0.97% on NSE (₹2,316.30).
Natco Pharma is down 0.89% on BSE (₹1,081.95) and 0.75% on NSE (₹1,083.35).
Orchid Pharma has slipped 0.56% on BSE (₹564.35).
Sun Pharma, the sector’s largest listed company, is down a mild 0.44% on BSE at ₹1,689.20 and 0.48% on NSE at ₹1,688.40.
Broadly steady stocks
Several names are close to flat, including Cipla (-0.12% BSE), Mankind Pharma (-0.11% BSE), Indoco Remedies (-0.25% BSE), Biocon (+0.17% BSE), and Zydus Lifesciences (+0.13% BSE). Wockhardt is up 0.20% on BSE (₹1,355.00).
Sector indices
The S&P BSE Healthcare index is at 43,189.07, down 0.10% in early trade. The broader Sensex is up 0.52% at 78,519.15 and the Nifty 50 is up 0.39% at 24,326.80.
Data sourced from BSE (09:37 AM) and NSE (09:39 AM), April 16, 2026. This is a factual price summary and does not constitute investment advice.